Related Experiment Video
Updated: Aug 19, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Molecular mechanism for accelerated atherosclerosis in diabetes and its potential therapeutic intervention
S Yamagishi1, K Nakamura, M Takeuchi
1Department of Internal Medicine III, Kurume University School of Medicine, Kurume, Japan. shoichi@med.kurume-u.ac.jp
Insights
Diabetes accelerates atherosclerosis, increasing vascular disease risk. This review explores molecular mechanisms and therapeutic targets like postprandial hyperglycemia and advanced glycation end products (AGEs).
Area of Science:
- Cardiovascular Science
- Endocrinology
- Metabolic Disease Research
Background:
- Diabetes significantly elevates the risk of atherosclerotic vascular disorders, including coronary, cerebrovascular, and peripheral artery disease.
- Macrovascular complications in diabetes contribute substantially to patient disability and mortality.
- Current evidence suggests limited cardiovascular benefits from strict blood glucose control alone in diabetic patients.
Purpose of the Study:
- To review the molecular mechanisms underlying accelerated atherosclerosis in diabetes.
- To discuss potential therapeutic interventions targeting diabetes-related vascular complications.
- To specifically focus on the roles of postprandial hyperglycemia and advanced glycation end products (AGEs).
Main Methods:
- Literature review of molecular mechanisms in diabetes-accelerated atherosclerosis.
- Analysis of studies on therapeutic interventions for diabetic macrovascular complications.
- Focus on research concerning postprandial hyperglycemia and AGEs in vascular disease.
Main Results:
- Diabetes promotes atherosclerosis through various molecular pathways.
- Postprandial hyperglycemia and AGEs are key contributors to vascular damage in diabetes.
- Targeting these specific mechanisms may offer new therapeutic avenues.
Conclusions:
- Accelerated atherosclerosis in diabetes is driven by specific molecular factors beyond general hyperglycemia.
- Interventions targeting postprandial hyperglycemia and AGEs show promise for mitigating cardiovascular risk in diabetes.
- Further research into these pathways is crucial for developing effective treatments for diabetic vascular complications.
Abstract:
Diabetes is associated with a marked increase in the risk of atherosclerotic vascular disorders, including coronary, cerebrovascular and peripheral artery disease. Macrovascular complications could account for disabilities and high mortality rates in patients with diabetes. There is a growing body of evidence to indicate that tight blood glucose control has no more than a marginal impact on cardiovascular disease in diabetes. In this review, we discuss the molecular mechanisms for accelerated atherosclerosis in diabetes and the potential therapeutic interventions, especially focusing on postprandial hyperglycemia and advanced glycation end products (AGEs).
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease I: Introduction
Atherosclerosis III: Management
Type II Diabetes II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes I: Introduction